183 related articles for article (PubMed ID: 26337085)
1. A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel.
Bida O; Gidoni M; Ideses D; Efroni S; Ginsberg D
Oncotarget; 2015 Sep; 6(29):27880-90. PubMed ID: 26337085
[TBL] [Abstract][Full Text] [Related]
2. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813.
Hu P; Shangguan J; Zhang L
Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769
[TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.
Booy EP; McRae EK; Koul A; Lin F; McKenna SA
Mol Cancer; 2017 Jun; 16(1):109. PubMed ID: 28651607
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
6. A novel lncRNA, GASL1, inhibits cell proliferation and restricts E2F1 activity.
Gasri-Plotnitsky L; Ovadia A; Shamalov K; Nizri-Megnaji T; Meir S; Zurer I; Cohen CJ; Ginsberg D
Oncotarget; 2017 Apr; 8(14):23775-23786. PubMed ID: 28423601
[TBL] [Abstract][Full Text] [Related]
7. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics.
Xiao Z; Xue J; Semizarov D; Sowin TJ; Rosenberg SH; Zhang H
Int J Cancer; 2005 Jul; 115(4):528-38. PubMed ID: 15688426
[TBL] [Abstract][Full Text] [Related]
8. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
9. Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer.
Xu S; Wang P; Zhang J; Wu H; Sui S; Zhang J; Wang Q; Qiao K; Yang W; Xu H; Pang D
Mol Cancer; 2019 Apr; 18(1):89. PubMed ID: 30999914
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00341 mediates PM
Xu Y; Wu J; Peng X; Yang T; Liu M; Chen L; Dai X; Wang Z; Yang C; Yan B; Jiang Y
Toxicol Lett; 2017 Jul; 276():1-10. PubMed ID: 28366736
[TBL] [Abstract][Full Text] [Related]
11. Downregulated long non-coding RNA CLMAT3 promotes the proliferation of colorectal cancer cells by targeting regulators of the cell cycle pathway.
Ye LC; Chen T; Zhu DX; Lv SX; Qiu JJ; Xu J; Yuan FL; Wei Y
Oncotarget; 2016 Sep; 7(37):58931-58938. PubMed ID: 27391344
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma.
Zhai W; Li X; Wu S; Zhang Y; Pang H; Chen W
Int J Oncol; 2015 May; 46(5):2125-37. PubMed ID: 25695231
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
14. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
Chang WL; Yu CC; Chen CS; Guh JH
Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer.
Ma MZ; Kong X; Weng MZ; Zhang MD; Qin YY; Gong W; Zhang WJ; Quan ZW
Mol Carcinog; 2015 Nov; 54(11):1397-406. PubMed ID: 25213660
[TBL] [Abstract][Full Text] [Related]
16. A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer.
Yang Q; Xu E; Dai J; Liu B; Han Z; Wu J; Zhang S; Peng B; Zhang Y; Jiang Y
Toxicol Appl Pharmacol; 2015 Jun; 285(2):79-88. PubMed ID: 25888808
[TBL] [Abstract][Full Text] [Related]
17. Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer.
Tracy KM; Tye CE; Ghule PN; Malaby HLH; Stumpff J; Stein JL; Stein GS; Lian JB
Mol Cancer Res; 2018 Apr; 16(4):587-598. PubMed ID: 29378907
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-AP001631.9 promotes cell migration in gastric cancer.
Cai H; Ye X; He B; Li Q; Li Y; Gao Y
Int J Clin Exp Pathol; 2015; 8(6):6235-44. PubMed ID: 26261500
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line.
Barboule N; Chadebech P; Baldin V; Vidal S; Valette A
Oncogene; 1997 Dec; 15(23):2867-75. PubMed ID: 9419978
[TBL] [Abstract][Full Text] [Related]
20. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
